Manufacturers object to provisions in FDA’s microbiological quality guidance
Regulatory NewsJoanne S. Eglovitch
Chemistry, Manufacturing and Controls (CMC)ComplianceEnvironmentalNorth AmericaOTCPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy